Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Gregory L. Weaver
Age : 64
Public asset : 69,010 USD
Linked companies : Atai Life Sciences N.V. - Atossa Therapeutics, Inc. - NOXXON Pharma N.V.
Summary 
Currently, Gregory L. Weaver is Chief Financial Officer at ATAI Life Sciences NV. Mr. Weaver is also on the board of Atossa Therapeutics, Inc. and NOXXON Pharma NV.

In his past career he held the position of Chief Financial Officer at Poniard Pharmaceuticals, Inc., Chief Financial Officer & Senior Vice President of Celsion Corp., Global Chief Financial Officer & Executive VP at Oryzon Genomics SA, Chief Financial & Accounting Officer at Eloxx Pharmaceuticals, Inc. and Chief Financial Officer for Sevion Therapeutics, Inc. (a subsidiary of Eloxx Pharmaceuticals, Inc.), Chief Financial Officer, Secretary & VP at MDRNA, Inc., Chief Financial Officer & Senior Vice President at Sirna Therapeutics, Inc., CFO, Secretary, Treasurer & Senior Vice President at Fibrocell Science, Inc., Chief Financial Officer for ILEX Oncology, Inc., Chief Financial Officer at Liminal BioSciences, Inc., Chief Financial Officer of Prism Technologies, Inc., Chief Financial Officer for Verity Solutions Group, Inc. and Chief Financial Officer for Oncology, Inc.

He received an MBA from Boston College and an undergraduate degree from Trinity University.


Current positions of Gregory L. Weaver 
NameTitle Since
Atai Life Sciences N.V.
(Biotechnology & Medical Research)
Chief Financial Officer 2020
Atossa Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2013
NOXXON Pharma N.V.
(Biotechnology & Medical Research)
Member-Supervisory Board 2021


Holdings of Gregory L. Weaver 
NameEquities%Valuation
Atai Life Sciences N.V. (ATAI)
(Biotechnology & Medical Research)
4,6660.0030%69,010 USD


Gregory L. Weaver: Personal Network 
Most Read News 
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
RE
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/11JAMIE DIMON : JPMorgan's Dimon blasts bitcoin as 'worthless', due for regulation
RE
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
RE
10/18MATTHEW MOULDING : THG's Moulding gives up 'golden share' after stock tumbles
RE
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
DJ
More news


© 2021 People and Ownership :   
Gregory L. Weaver : Connections